Atypical Anti-psychotics (long-acting injectable)

Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.

  • Revision history
    • Oct. 2021, Sept. 2019
  • Initially developed
    • Sept. 2017